Journal article
Epigenetic modification of the norepinephrine transporter gene in postural tachycardia syndrome
R Bayles, H Kn, E Lambert, EK Baker, A Agrotis, L Guo, JBM Jowett, M Esler, G Lambert, A El-Osta
Arteriosclerosis Thrombosis and Vascular Biology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2012
Abstract
Objective-The postural tachycardia syndrome (POTS) has multiple symptoms, chief among which are tachycardia, weakness, and recurrent blackouts while standing. Previous research has implicated dysfunction of the norepinephrine transporter. A coding mutation in the norepinephrine transporter gene (SLC6A2) sequence has been reported in 1 family kindred only. The goal of the present study was to further characterize the role and regulation of the SLC6A2 gene in POTS. Methods and Results-Sympathetic nervous system responses to head-up tilt were examined by combining norepinephrine plasma kinetics measurements and muscle sympathetic nerve activity recordings in patients with POTS compared with tha..
View full abstractGrants
Funding Acknowledgements
We acknowledge the grant and fellowship support from the National Health and Medical Research Council (NHMRC). This work was supported, in part, by the Victorian Government's Operational Infrastructure Support Program.